Vitamin B6 & B12 Supports memory, concentration, and nervous system health
MDM2 Inhibitor Nutlin-3a Triggers Augophagic Cell Death In Addition to Apoptosis In Leukemia Cell Lines with Wild-Type p53
Subcutaneous injections have been used safely for over a century
GLP-1 RAs Hold Promising Potential for Reduction of Cardiometabolic Risk Factors additional benefits : Brain: Appetite suppression, nerve protection, and decreased neuroinflammation Heart: Decreased blood pressure (systolic and diastolic), reduced total cholesterol levels, lowered endothelial dysfunction, and increased heart rate Liver: Decreased glucose production Pancreas: Increased insulin secretion, decreased glucagon secretion, B islet cell proliferation GI Tract: Decreased gastric emptying Because these drugs cause weight loss, it is not clear whether the GLP-1 RAs or the weight loss reduces cardiometabolic risks
Semaglutide has rising clinical utility, both for its original purpose in managing type-II diabetes symptoms and, more recently, as a tool for weight management
Wang C, Shi W, Xu J, Huang C, Zhu J